School of Medicine
Showing 1-10 of 11 Results
Bing Professor of Human Biology and Senior Fellow at the Stanford Institute for Economic Policy Research
Current Research and Scholarly Interests Dr. Baker's research is in the area of health economics, and focuses on the effects of financial incentives, organizational structures, and government policies on the health care delivery system, health care costs, and health outcomes.
Current Research and Scholarly Interests Dr. Bannett seeks to use data-driven methods to develop reliable quality measures for management of children with developmental and behavioral (DB) conditions in community-based primary care. Current observational studies use multi-level analysis of electronic health record data and clinician interviews. Dr. Bannett plans to use natural language processing to accurately assess quality of care, with the ultimate goal of improving health care delivery for children with DB conditions.
Associate Professor of Medicine (Primary Care and Population Health), Senior Fellow at the Woods Institute for the Environment and Associate Professor, by courtesy, of Health Research and Policy
Current Research and Scholarly Interests Effect of global health policies on health of individuals in developing countries, global health, HIV and TB.
Professor of Medicine, Senior Fellow at the Stanford Institute for Economic Policy Research and, by courtesy, at the Freeman Spogli Institute and Professor, by courtesy, of Health Research and Policy and of Economics
Current Research and Scholarly Interests My research focuses on the constraints that vulnerable populations face in making decisions that affect their health status, as well as the effects of government policies and programs designed to benefit vulnerable populations.
Professor (Research) of Health Research and Policy, Emeritus
Bio I received my PhD. in Mathematical Statistics in 1967. I joined the research community at the Stanford University School of Medicine, Division of Immunology & Rheumatology, in 1984 as head statistician directing the biostatistics consulting and analytic support of the Arthritis Rheumatism Aging Medical Information System (ARAMIS) and Multipurpose Arthritis Center (MAC) grant-related research programs. In 1993 I was appointed Associate Professor with a joint appointment in the Departments of Medicine and of Health Research & Policy, and am currently Professor of Biostatistics at Stanford University, emeritus since 2007. My contributions to the statistics literature span numerous fields, including methods of sample size estimation, efficiency and bias of estimators, research methods for kappa statistics, non-parametric classification methods and methods of assessing multi-parameter endpoints. I have over 200 peer-reviewed publications. I have been directly involved with the development of numerous criteria rules for classification of diseases and with establishing guidelines for clinical trial research and in proposing responder criteria for osteoarthritis drugs. Since 1987, I have been a consultant on an ad hoc basis to pharmaceutical and biotechnical firms, including both start-up and established companies. I have extensive experience with devices, drugs and biologics and have participated in all aspects of applying statistics to implement investigational plans; e.g.: for protocol development, design of trials, database design. I?ve been a member of the FDA Statistical Advisors Panel, the statistical member on numerous data safety monitoring boards, and frequently represent companies at meetings with the FDA
Melissa L Bondy
Professor of Epidemiology and Population Health
Bio Dr. Melissa Bondy is the inaugural chair of the Department of Epidemiology and Population Health and the Associate Director for Population Sciences at the Stanford Cancer Institute. Before joining Stanford, she was Associate Director of Cancer Prevention and Population Sciences and section chair of Epidemiology and Population Sciences at Baylor College of Medicine. Her research focus is in genetic and molecular epidemiology and is at the forefront of developing innovative ways to assess the roles of heredity and genetic susceptibility in the etiology of cancer and outcomes, primarily brain and breast cancer. Currently, she leads the largest family study of glioma patients, as well as a study of molecular predictors of outcome for glioma patients. She has a strong interest in health disparities and has a current study to investigate the ethnic differences in glioma. She has been working on studying the health effects of exposure to Hurricane Harvey. She serves on the National Cancer Institute?s (NCI) Board of Scientific Advisors, where she provides direct counsel to the Director of the NCI, and is a member of the External Advisory Board for several NCI-designated cancer centers. In 2018, she received the Visiting Scholar Award from the NCI Division of Cancer Epidemiology and Genetics.